Literature DB >> 25201131

Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

Christopher J Earley1, James Connor2, Diego Garcia-Borreguero3, Peter Jenner4, John Winkelman5, Phyllis C Zee6, Richard Allen7.   

Abstract

Restless legs syndrome (RLS), also known as Willis-Ekbom Disease (WED), is a sensorimotor disorder for which the exact pathophysiology remains unclear. Brain iron insufficiency and altered dopaminergic function appear to play important roles in the etiology of the disorder. This concept is based partly on extensive research studies using cerebrospinal fluid (CSF), autopsy material, and brain imaging indicating reduced regional brain iron and on the clinical efficacy of dopamine receptor agonists for alleviating RLS symptoms. Finding causal relations, linking low brain iron to altered dopaminergic function in RLS, has required however the use of animal models. These models have provided insights into how alterations in brain iron homeostasis and dopaminergic system may be involved in RLS. The results of animal models of RLS and biochemical, postmortem, and imaging studies in patients with the disease suggest that disruptions in brain iron trafficking lead to disturbances in striatal dopamine neurotransmission for at least some patients with RLS. This review examines the data supporting an iron deficiency-dopamine metabolic theory of RLS by relating the results from animal model investigations of the influence of brain iron deficiency on dopaminergic systems to data from clinical studies in patients with RLS.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Dopamine; Hypoxia-inducible factor; Imaging; Iron deficiency; Sleep disorders

Mesh:

Substances:

Year:  2014        PMID: 25201131     DOI: 10.1016/j.sleep.2014.05.009

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  83 in total

1.  [Frequent neurological diseases associated with the restless legs syndrome].

Authors:  M Bartl; J Winkelmann; B Högl; W Paulus; C Trenkwalder
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 2.  Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.

Authors:  Susan Mackie; John W Winkelman
Journal:  CNS Drugs       Date:  2015-05       Impact factor: 5.749

3.  Sleep in Autism Spectrum Disorders.

Authors:  Olivia J Veatch; Angela C Maxwell-Horn; Beth A Malow
Journal:  Curr Sleep Med Rep       Date:  2015-06

4.  The Adenosine Hypothesis of Restless Legs Syndrome.

Authors:  Sergi Ferré
Journal:  J Caffeine Adenosine Res       Date:  2019-03-14

Review 5.  Therapies for Restless Legs in Parkinson's Disease.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2019-11-09       Impact factor: 3.598

6.  To what extent and why are COPD and Willis-Ekbom disease associated?

Authors:  Tugba Mandal; Şenay Aydın; Dilek Kanmaz; Ahmet Levent Karasulu; Gülfidan Aras; Esin Tuncay
Journal:  Sleep Breath       Date:  2016-05-30       Impact factor: 2.816

7.  Acute Drug-Induced Symptoms of Restless Legs Syndrome in an Emergency Department.

Authors:  Mariusz Sieminski; Lukasz Zemojtel
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

8.  Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-07-31       Impact factor: 3.332

9.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

Review 10.  Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  Guang Jian Liu; Lang Wu; Song Lin Wang; Li Li Xu; Li Ying Chang; Yun Fu Wang
Journal:  Clin Ther       Date:  2015-11-11       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.